Brief: PCI Biotech Extends Preclinical Research Collaboration Agreement With Pharma Company

PCI Biotech Holding ASA

22/07/2019 07:06

July 22 (Reuters) - PCI Biotech Holding ASA  PCIB.OL :
    * REG-PCI BIOTECH: EXTENSION OF PRECLINICAL RESEARCH
COLLABORATION
AGREEMENT WITH A TOP-10 LARGE PHARMA COMPANY
    * REG-PCI BIOTECH: EXTENSION OF PRECLINICAL RESEARCH
COLLABORATION
AGREEMENT WITH A TOP-10 LARGE PHARMA COMPANY
    * EXTENDING PRECLINICAL RESEARCH COLLABORATION WITH AN
UNDISCLOSED
TOP-10 PHARMA COMPANY.
    * RESEARCH COLLABORATION IS EXTENDED WITH 6 MONTHS UNTIL END
OF
2019
    * COMPANIES HAVE AGREED TO THEREAFTER USE FOLLOWING 6 MONTHS
(UNTIL END JUNE 2020) TO EVALUATE POTENTIAL FOR A FURTHER
PARTNERSHIP.

Source text for Eikon:  ID:nGNE9LzhfT 
Further company coverage:  PCIB.OL 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))